3PXD

Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: R1835P


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.80 Å
  • R-Value Free: 0.281 
  • R-Value Work: 0.233 
  • R-Value Observed: 0.236 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

Impact of BRCA1 BRCT Domain Missense Substitutions on Phosphopeptide Recognition.

Coquelle, N.Green, R.Glover, J.N.

(2011) Biochemistry 50: 4579-4589

  • DOI: 10.1021/bi2003795
  • Structures With Same Primary Citation

  • PubMed Abstract: 
  • The BRCA1 BRCT domain binds pSer-x-x-Phe motifs in partner proteins to regulate the cellular response to DNA damage. Approximately 120 distinct missense variants have been identified in the BRCA1 BRCT through breast cancer screening, and several of t ...

    The BRCA1 BRCT domain binds pSer-x-x-Phe motifs in partner proteins to regulate the cellular response to DNA damage. Approximately 120 distinct missense variants have been identified in the BRCA1 BRCT through breast cancer screening, and several of these have been linked to an increased cancer risk. Here we probe the structures and peptide-binding activities of variants that affect the BRCA1 BRCT phosphopeptide-binding groove. The results obtained from the G1656D and T1700A variants illustrate the role of Ser1655 in pSer recognition. Mutations at Arg1699 (R1699W and R1699Q) significantly reduce peptide binding through loss of contacts to the main chain of the Phe(+3) residue and, in the case of R1699W, to a destabilization of the BRCT fold. The R1835P and E1836K variants do not dramatically reduce peptide binding, in spite of the fact that these mutations significantly alter the structure of the walls of the Phe(+3) pocket.


    Related Citations: 
    • Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays.
      Lee, M.S., Green, R., Marsillac, S.M., Coquelle, N., Williams, R.S., Yeung, T., Foo, D., Hau, D.D., Hui, B., Monteiro, A.N., Glover, J.N.
      (2010) Cancer Res 70: 4880
    • Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
      Williams, R.S., Lee, M.S., Hau, D.D., Glover, J.N.
      (2004) Nat Struct Mol Biol 11: 519
    • Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
      Clapperton, J.A., Manke, I.A., Lowery, D.M., Ho, T., Haire, L.F., Yaffe, M.B., Smerdon, S.J.
      (2004) Nat Struct Mol Biol 11: 512
    • Structural consequences of a cancer-causing BRCA1-BRCT missense mutation.
      Williams, R.S., Glover, J.N.
      (2003) J Biol Chem 278: 2630

    Organizational Affiliation

    Department of Biochemistry, School of Medicine, University of Alberta, Edmonton, AB, Canada.



Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Breast cancer type 1 susceptibility protein
A
214Homo sapiensMutation(s): 1 
Gene Names: BRCA1RNF53
EC: 6.3.2 (PDB Primary Data), 2.3.2.27 (UniProt)
Find proteins for P38398 (Homo sapiens)
Go to UniProtKB:  P38398
NIH Common Fund Data Resources
PHAROS  P38398
Protein Feature View
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
SO4
Query on SO4

Download CCD File 
A
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
 Ligand Interaction
NI
Query on NI

Download CCD File 
A
NICKEL (II) ION
Ni
VEQPNABPJHWNSG-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.80 Å
  • R-Value Free: 0.281 
  • R-Value Work: 0.233 
  • R-Value Observed: 0.236 
  • Space Group: P 61 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 114.95α = 90
b = 114.95β = 90
c = 121.94γ = 120
Software Package:
Software NamePurpose
MxDCdata collection
PHASERphasing
PHENIXrefinement
XDSdata reduction
XSCALEdata scaling

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2011-04-20
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2017-11-08
    Changes: Refinement description